BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16449973)

  • 1. BubR1 is involved in regulation of DNA damage responses.
    Fang Y; Liu T; Wang X; Yang YM; Deng H; Kunicki J; Traganos F; Darzynkiewicz Z; Lu L; Dai W
    Oncogene; 2006 Jun; 25(25):3598-605. PubMed ID: 16449973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.
    Ha GH; Baek KH; Kim HS; Jeong SJ; Kim CM; McKeon F; Lee CW
    Cancer Res; 2007 Aug; 67(15):7155-64. PubMed ID: 17671183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints.
    Sabisz M; Wesierska-Gadek J; Skladanowski A
    Biochem Pharmacol; 2010 May; 79(10):1387-97. PubMed ID: 20067769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
    Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
    J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1.
    Cazzalini O; Donà F; Savio M; Tillhon M; Maccario C; Perucca P; Stivala LA; Scovassi AI; Prosperi E
    DNA Repair (Amst); 2010 Jun; 9(6):627-35. PubMed ID: 20303835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p55CDC/hCDC20 is associated with BUBR1 and may be a downstream target of the spindle checkpoint kinase.
    Wu H; Lan Z; Li W; Wu S; Weinstein J; Sakamoto KM; Dai W
    Oncogene; 2000 Sep; 19(40):4557-62. PubMed ID: 11030144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BubR1 deficiency results in enhanced activation of MEK and ERKs upon microtubule stresses.
    Yang YL; Duan Q; Guo TB; Wang XX; Ruan Q; Xu GT; Zhang JW; Lu ZY; Xu M; Lu L; Dai W
    Cell Prolif; 2007 Jun; 40(3):397-410. PubMed ID: 17531083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase-1 inhibits ATM kinase activity in DNA damage response.
    Watanabe F; Fukazawa H; Masutani M; Suzuki H; Teraoka H; Mizutani S; Uehara Y
    Biochem Biophys Res Commun; 2004 Jun; 319(2):596-602. PubMed ID: 15178448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
    Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
    EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
    Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
    J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotic functions of poly(ADP-ribose) polymerases.
    Slade D
    Biochem Pharmacol; 2019 Sep; 167():33-43. PubMed ID: 30910692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of early biphasic activation of poly(ADP-ribose) polymerase-1 in response to ultraviolet B radiation.
    Vodenicharov MD; Ghodgaonkar MM; Halappanavar SS; Shah RG; Shah GM
    J Cell Sci; 2005 Feb; 118(Pt 3):589-99. PubMed ID: 15657079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BUBR1 phosphorylation is regulated during mitotic checkpoint activation.
    Li W; Lan Z; Wu H; Wu S; Meadows J; Chen J; Zhu V; Dai W
    Cell Growth Differ; 1999 Nov; 10(11):769-75. PubMed ID: 10593653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BubR1 is required for the mitotic block induced by combretastatin-A4 and a novel cis-restricted ß-lactam analogue in human cancer cells.
    Greene LM; Carr M; Keeley NO; Lawler M; Meegan MJ; Zisterer DM
    Int J Mol Med; 2011 May; 27(5):715-23. PubMed ID: 21369694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Aurora-B kinase activity by poly(ADP-ribosyl)ation in response to DNA damage.
    Monaco L; Kolthur-Seetharam U; Loury R; Murcia JM; de Murcia G; Sassone-Corsi P
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14244-8. PubMed ID: 16179389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage.
    Lee JH; Kang Y; Khare V; Jin ZY; Kang MY; Yoon Y; Hyun JW; Chung MH; Cho SI; Jun JY; Chang IY; You HJ
    Oncogene; 2010 Mar; 29(10):1431-50. PubMed ID: 20023697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1.
    Oikawa T; Okuda M; Ma Z; Goorha R; Tsujimoto H; Inokuma H; Fukasawa K
    Mol Cell Biol; 2005 May; 25(10):4046-61. PubMed ID: 15870277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
    Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
    Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.
    Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ
    Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency.
    Dai W; Wang Q; Liu T; Swamy M; Fang Y; Xie S; Mahmood R; Yang YM; Xu M; Rao CV
    Cancer Res; 2004 Jan; 64(2):440-5. PubMed ID: 14744753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.